Cargando…

6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities

A recently emerged betacoronavirus, SARS-CoV-2, has led to a global health crisis that calls for the identification of effective therapeutics for COVID-19 disease. Coronavirus papain-like protease (PLpro) is an attractive drug target as it is essential for viral polyprotein cleavage and for deconjug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swaim, Caleb D., Perng, Yi-Chieh, Zhao, Xu, Canadeo, Larissa A., Harastani, Houda H., Darling, Tamarand L., Boon, Adrianus C. M., Lenschow, Deborah J., Huibregtse, Jon M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337375/ https://www.ncbi.nlm.nih.gov/pubmed/32637945 http://dx.doi.org/10.1101/2020.07.01.183020

Ejemplares similares

6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro
por: Swaim, Caleb D., et al.
Publicado: (2021)

Modulation of Extracellular ISG15 Signaling by Pathogens and Viral Effector Proteins
por: Swaim, Caleb D., et al.
Publicado: (2020)

A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters
por: Ying, Baoling, et al.
Publicado: (2023)

Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
por: Klemm, Theresa, et al.
Publicado: (2020)

In vitro replication and thermodynamic studies of methylation and oxidation modifications of 6-thioguanine
por: Gu, Chunang, et al.
Publicado: (2007)

Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
por: Chu, Hsu-Feng, et al.
Publicado: (2018)

Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication
por: Bajaj, Teena, et al.
Publicado: (2023)

Genetically Encoded Fluorescent Sensors for SARS-CoV-2 Papain-like Protease PLpro
por: Sokolinskaya, Elena L., et al.
Publicado: (2022)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site
por: van Vliet, Vera J. E., et al.
Publicado: (2022)

6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2
por: Chuang, Shang-Ju, et al.
Publicado: (2018)

Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
por: Narayanan, Anoop, et al.
Publicado: (2022)

Crosslinking of DNA repair and replication proteins to DNA in cells treated with 6-thioguanine and UVA
por: Gueranger, Quentin, et al.
Publicado: (2011)

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach
por: Sencanski, Milan, et al.
Publicado: (2022)

Inhibitors of SARS-CoV-2 PLpro
por: Calleja, Dale J., et al.
Publicado: (2022)

6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling
por: Yin, Yuebang, et al.
Publicado: (2018)

ISG15 in antiviral immunity and beyond
por: Perng, Yi-Chieh, et al.
Publicado: (2018)

Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes
por: Tan, Jinlin, et al.
Publicado: (2022)

Deciphering the Potential of Pre and Pro-Vitamin D of Mushrooms against Mpro and PLpro Proteases of COVID-19: An In Silico Approach
por: Tiwari, Abhay, et al.
Publicado: (2022)

Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15)
por: Gold, Inbar Magid, et al.
Publicado: (2022)

Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity
por: Kawall, Anasha, et al.
Publicado: (2023)

A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
por: Bricker, Traci L., et al.
Publicado: (2021)

The highly conserved stem-loop II motif is dispensable for SARS-CoV-2
por: Jiang, Hongbing, et al.
Publicado: (2023)

The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2
por: Jiang, Hongbing, et al.
Publicado: (2023)

Effect of 6-thioguanine on the stability of duplex DNA
por: Bohon, Jen, et al.
Publicado: (2005)

SARS-COV-2 Coronavirus Papain-like Protease PLpro as an Antiviral Target for Inhibitors of Active Site and Protein–Protein Interactions
por: Ershov, P. V., et al.
Publicado: (2023)

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine
por: Bayoumy, Ahmed B., et al.
Publicado: (2021)

SARS-CoV-2: the many pros of targeting PLpro
por: McClain, Christopher B., et al.
Publicado: (2020)

The first cases of collagenous sprue successfully treated with thioguanine
por: van Gils, Tom, et al.
Publicado: (2016)

Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike‐ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics
por: Gil‐Moles, Maria, et al.
Publicado: (2020)

Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies
por: Ali Dahhas, Mohammed, et al.
Publicado: (2023)

Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
por: Lewis, Devin S. M., et al.
Publicado: (2022)

Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro
por: Alaofi, Ahmed L., et al.
Publicado: (2022)

Quantification of thioguanine-resistant lymphocytes from mice irradiated in vivo.
por: Lorenz, R, et al.
Publicado: (1990)

JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis
por: Son, Juhee, et al.
Publicado: (2022)

Crystal structure of a DNA duplex cross-linked by 6-thioguanine–6-thioguanine disulfides: reversible formation and cleavage catalyzed by Cu(ii) ions and glutathione
por: Ono, Akira, et al.
Publicado: (2019)

Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling
por: Hariono, Maywan, et al.
Publicado: (2019)

Human Cytomegalovirus pUL79 Is an Elongation Factor of RNA Polymerase II for Viral Gene Transcription
por: Perng, Yi-Chieh, et al.
Publicado: (2014)

6-Thioguanine: Antimitotic Effect on Human Lymphocytes in vitro Prevented by Adenine
por: Price, D. J., et al.
Publicado: (1971)

Cannot write session to /tmp/vufind_sessions/sess_jdm4p96bb4l8ofv599sjd00ub4